[go: up one dir, main page]

PT91580A - Processo para a preparacao de compostos de nicotinamida n-substituida antidepressivos - Google Patents

Processo para a preparacao de compostos de nicotinamida n-substituida antidepressivos

Info

Publication number
PT91580A
PT91580A PT91580A PT9158089A PT91580A PT 91580 A PT91580 A PT 91580A PT 91580 A PT91580 A PT 91580A PT 9158089 A PT9158089 A PT 9158089A PT 91580 A PT91580 A PT 91580A
Authority
PT
Portugal
Prior art keywords
substitute
fluoro
chloro
preparation
nicotinamide compounds
Prior art date
Application number
PT91580A
Other languages
English (en)
Other versions
PT91580B (pt
Inventor
Nicholas Alex Saccomano
Fredic J Vinick
Original Assignee
Pfizer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer filed Critical Pfizer
Publication of PT91580A publication Critical patent/PT91580A/pt
Publication of PT91580B publication Critical patent/PT91580B/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/78—Carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D213/81—Amides; Imides
    • C07D213/82—Amides; Imides in position 3
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/26—Psychostimulants, e.g. nicotine, cocaine
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Neurosurgery (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Neurology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Psychiatry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Biomedical Technology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pain & Pain Management (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyridine Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Compounds Of Unknown Constitution (AREA)
  • Macromonomer-Based Addition Polymer (AREA)
  • Saccharide Compounds (AREA)
PT91580A 1988-08-31 1989-08-30 Processo para a preparacao de compostos de nicotinamida n-substituida antidepressivos PT91580B (pt)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US07/238,951 US4861891A (en) 1988-08-31 1988-08-31 Antidepressant N-substituted nicotinamide compounds

Publications (2)

Publication Number Publication Date
PT91580A true PT91580A (pt) 1990-03-08
PT91580B PT91580B (pt) 1995-05-04

Family

ID=22899998

Family Applications (1)

Application Number Title Priority Date Filing Date
PT91580A PT91580B (pt) 1988-08-31 1989-08-30 Processo para a preparacao de compostos de nicotinamida n-substituida antidepressivos

Country Status (18)

Country Link
US (1) US4861891A (pt)
EP (1) EP0357316B1 (pt)
JP (1) JPH02115168A (pt)
KR (1) KR920000760B1 (pt)
AT (1) ATE88182T1 (pt)
AU (1) AU609329B2 (pt)
CA (1) CA1329605C (pt)
DE (1) DE68905979T2 (pt)
DK (1) DK426889A (pt)
FI (1) FI894066A (pt)
HU (1) HU208120B (pt)
IE (1) IE892775L (pt)
IL (1) IL91417A0 (pt)
MY (1) MY104179A (pt)
NO (1) NO893471L (pt)
NZ (1) NZ230493A (pt)
PT (1) PT91580B (pt)
ZA (1) ZA896626B (pt)

Families Citing this family (36)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4973597A (en) * 1989-06-30 1990-11-27 Eli Lilly And Company Anticonvulsant agents
US5395935A (en) * 1992-05-08 1995-03-07 Pfizer Inc. Endo-bicyclo[2.2.1]heptan-2-ol and derived pharmaceutical agents
TW429148B (en) * 1995-10-27 2001-04-11 Pfizer Pharmaceutical agents for the treatment of acute and chronic inflammatory diseases
GB9602166D0 (en) * 1996-02-02 1996-04-03 Zeneca Ltd Aminoheterocyclic derivatives
CN1254335A (zh) * 1997-04-04 2000-05-24 辉瑞产品公司 烟酰胺衍生物
GB9715584D0 (en) * 1997-07-23 1997-10-01 Eisai Co Ltd Compounds
CA2396458C (en) * 2000-01-31 2006-12-05 Pfizer Products Inc. Pyrimidine carboxamides useful as inhibitors of pde4 isozymes
CZ20022410A3 (cs) * 2000-01-31 2003-08-13 Pfizer Products Inc. Benzoanelované heterocyklylové deriváty nikotinamidu užitečné jako selektivní inhibitory isozymů PDE4
KR100661081B1 (ko) * 2000-06-10 2006-12-26 동화약품공업주식회사 항바이러스제로 유용한 6-메틸니코틴아미드 유도체
PL365443A1 (en) * 2001-01-31 2005-01-10 Pfizer Products Inc. Thiazolyl-, oxazolyl-, pyrrolyl-, and imidazolyl-acid amide derivatives useful as inhibitors of pde4 isozymes
EA200300621A1 (ru) * 2001-01-31 2003-12-25 Пфайзер Продактс Инк. Биарильные производные никотинамида, полезные в качестве ингибиторов изоферментов pde4
NZ526531A (en) 2001-01-31 2005-02-25 Pfizer Prod Inc Ether derivatives useful as inhibitors of phosphodiesterase type IV (PDE4) isozymes
US7250518B2 (en) * 2001-01-31 2007-07-31 Pfizer Inc. Nicotinamide acids, amides, and their mimetics active as inhibitors of PDE4 isozymes
US20050079548A1 (en) * 2003-07-07 2005-04-14 Plexxikon, Inc. Ligand development using PDE4B crystal structures
GB0317472D0 (en) * 2003-07-25 2003-08-27 Pfizer Ltd Nicotinamide derivatives useful as PDE4 inhibitors
AU2005325271A1 (en) * 2004-05-06 2006-07-27 Plexxikon, Inc. PDE4B inhibitors and uses therefor
JP2008512380A (ja) * 2004-09-03 2008-04-24 プレキシコン，インコーポレーテッド Ｐｄｅ４ｂ阻害剤
EP2258357A3 (en) 2005-08-26 2011-04-06 Braincells, Inc. Neurogenesis with acetylcholinesterase inhibitor
CA2620333A1 (en) 2005-08-26 2007-03-01 Braincells, Inc. Neurogenesis by muscarinic receptor modulation
WO2007047978A2 (en) 2005-10-21 2007-04-26 Braincells, Inc. Modulation of neurogenesis by pde inhibition
EP2314289A1 (en) 2005-10-31 2011-04-27 Braincells, Inc. Gaba receptor mediated modulation of neurogenesis
SI1951663T1 (sl) * 2005-11-24 2016-10-28 Dompe Farmaceutici S.P.A. Derivati (R)-arilalkilamino in farmacevtski sestavki, ki jih vsebujejo
WO2007098352A2 (en) * 2006-02-16 2007-08-30 Boehringer Ingelheim International Gmbh Substituted pyridineamide compounds useful as soluble epoxide hydrolase inhibitors
US20100216734A1 (en) 2006-03-08 2010-08-26 Braincells, Inc. Modulation of neurogenesis by nootropic agents
CA2651813A1 (en) 2006-05-09 2007-11-22 Braincells, Inc. Neurogenesis by modulating angiotensin
US7678808B2 (en) 2006-05-09 2010-03-16 Braincells, Inc. 5 HT receptor mediated neurogenesis
EP2068872A1 (en) 2006-09-08 2009-06-17 Braincells, Inc. Combinations containing a 4-acylaminopyridine derivative
US20100184806A1 (en) 2006-09-19 2010-07-22 Braincells, Inc. Modulation of neurogenesis by ppar agents
DE102007057089B4 (de) * 2006-12-22 2010-04-29 Lg Display Co., Ltd. Flüssigkristallanzeige mit Photosensor und Herstellungsverfahren derselben
EP2126574B1 (en) 2007-03-08 2015-12-23 The Board of Trustees of the Leland Stanford Junior University Mitochondrial aldehyde dehydrogenase-2 modulators and methods of use thereof
ES2477552T3 (es) 2008-09-08 2014-07-17 The Board Of Trustees Of The Leland Stanford Junior University Moduladores de la actividad de la aldehidodeshidrogenasa y métodos de uso de los mismos
WO2010062308A1 (en) 2008-10-28 2010-06-03 The Board Of Trustees Of The Leland Stanford Junior University Modulators of aldehyde dehydrogenase and methods of use thereof
WO2010099217A1 (en) 2009-02-25 2010-09-02 Braincells, Inc. Modulation of neurogenesis using d-cycloserine combinations
WO2012149106A1 (en) 2011-04-29 2012-11-01 The Board Of Trustees Of The Leland Stanford Junior University Compositions and methods for increasing proliferation of adult salivary stem cells
WO2013106547A1 (en) 2012-01-10 2013-07-18 President And Fellows Of Harvard College Beta-cell replication promoting compounds and methods of their use
WO2014160185A2 (en) * 2013-03-14 2014-10-02 The Board Of Trustees Of The Leland Stanford Junior University Mitochondrial aldehyde dehydrogenase-2 modulators and methods of use thereof

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4251263A (en) * 1979-09-04 1981-02-17 Stauffer Chemical Company N-substituted, 2-phenoxynicotinamide compounds and the herbicidal use thereof
US4270946A (en) * 1979-10-01 1981-06-02 Stauffer Chemical Company N-Aryl,2-phenoxy nicotinamide compounds and the herbicidal use thereof
IL64220A (en) * 1980-11-21 1985-06-30 May & Baker Ltd Nicotinamide derivatives,their preparation and their use as herbicides
US4692185A (en) * 1986-01-13 1987-09-08 Stauffer Chemical Company N-(ortho-substituted) benzyl, 3-trifluoromethylphenoxy nicotinamides as herbicides

Also Published As

Publication number Publication date
IE892775L (en) 1990-02-28
EP0357316A1 (en) 1990-03-07
HU208120B (en) 1993-08-30
DK426889D0 (da) 1989-08-30
KR900003154A (ko) 1990-03-23
EP0357316B1 (en) 1993-04-14
AU4091389A (en) 1990-06-28
FI894066A0 (fi) 1989-08-30
ATE88182T1 (de) 1993-04-15
MY104179A (en) 1994-02-28
AU609329B2 (en) 1991-04-26
FI894066A (fi) 1990-03-01
CA1329605C (en) 1994-05-17
IL91417A0 (en) 1990-04-29
NO893471L (no) 1990-03-01
KR920000760B1 (ko) 1992-01-21
DK426889A (da) 1990-03-01
DE68905979T2 (de) 1993-07-22
NO893471D0 (no) 1989-08-30
DE68905979D1 (de) 1993-05-19
HUT52058A (en) 1990-06-28
US4861891A (en) 1989-08-29
PT91580B (pt) 1995-05-04
NZ230493A (en) 1991-03-26
ZA896626B (en) 1991-04-24
JPH02115168A (ja) 1990-04-27

Similar Documents

Publication Publication Date Title
PT91580A (pt) Processo para a preparacao de compostos de nicotinamida n-substituida antidepressivos
CA2024572A1 (en) N-substituted-4-pyrimidinamines and-pyrimidinediamines, a process for their preparation and their use as medicaments
NO934792L (no) Xantinderivater
FI931707A0 (fi) 1,2,4-oxadiazolyl-fenoxialkylisoxazoler och deras anvaendning som virusmotarbetande aemnen
YU46787B (sh) Derivati heteroaril 3-okso-propan-nitrila i postupak za njihovo dobijanje
DE69022294D1 (de) N-Heteroaryl-purin-6-amine, Verfahren zu ihrer Herstellung und ihre Verwendung als Arzneimittel.
NZ221699A (en) Pyridazinone derivatives; pharmaceutical compositions and intermediates
ES2010284A6 (es) Procedimiento para preparar derivados de tiourea.
DK0395446T3 (da) N-acryloylpiperazinderivater, deres fremstilling og deres anvendelse som PAF-antagonister
DK369289D0 (da) Anvendelse af imidazopyrazolderivater som analgetica og antiinflammatoriske midler
PT87954A (pt) Processo para a preparacao de composicoes farmaceuticas contendo derivados de dioxopiperidina, com efeito antipsicotico
DE68902626D1 (de) Dioxopiperidinderivate enthaltende arzneimittel zur verbesserung des gedaechtnisses.

Legal Events

Date Code Title Description
FG3A Patent granted, date of granting

Effective date: 19941017

MM3A Annulment or lapse

Free format text: LAPSE DUE TO NON-PAYMENT OF FEES

Effective date: 19960430